Skip to main content
SpringerLink
Log in

TGF-β Signaling Alterations in Cancer

  • Chapter
Signal Transduction in Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 115))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Agrotis, A. Condron, M., & Bobik, A. (2000). Alternative splicing within the TGF-beta type I receptor gene (ALK-5) generates two major functional isoforms in vascular smooth muscle cells. FEBS Letters, 467, 128–132.

    Article  CAS  PubMed  Google Scholar 

  • Anbazhagan, R., Bornman, D. M., Johnston, J. C., Westra, W. H., & Gabrielson, E. (1999). The S387Y mutation of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma. Cancer Research, 59, 3363–3364.

    CAS  PubMed  Google Scholar 

  • Arkwright, P, D., Laurie, S., Super, M., Pravica, V., Schwarz, M. J., Webb, A. K., Hutchinson, I. V., (2000). TGF-beta(l) genotype and accelerated decline in lung function of patientswithcystic fibrosis. Thorax, 55, 459–462.

    Article  CAS  PubMed  Google Scholar 

  • Ashley, D. M., Kong, F. M., Bigner, D. D., & Hale, L. P, (1998). Endogenous expression of transforming growth factor beta-1 inhibits growth and tumorigenicity and enhancesfas-mediated apoptosis in a murine high-grade glioma model. Cancer Research, 58, 302–309.

    CAS  PubMed  Google Scholar 

  • Bandyopadhyay, A., Zhu, Y., Cibull, M. L., Bao, L. W., Chen, C. G., & Sun, L. Z. (1999). A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells. Cancer Research, 59, 5041–5046.

    CAS  PubMed  Google Scholar 

  • Bartlett, J. M., Langdon, S. P., Scott, W. N., Love, S. B., Miller, E. P., Katsaros, D., Smyth, J. F., & Miller, W. R. (1997). Transforming growth factor-beta isoform expression in human ovarian tumours. European Journal of Cancer, 33, 2397–2403.

    Article  CAS  PubMed  Google Scholar 

  • Bartsch, D., Hahn, S. A., Danichevski, K. D., Ramaswamy, A., Bastian, D., Galehdari, H., Barth, P., Schmiegel, W., Simon, B., & Rothmund, M. (1999). Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene, 18, 2367–2371.

    Article  CAS  PubMed  Google Scholar 

  • Baxter, S. W., Choong, D. Y. H., Eccles, D. M., & Campbell, I. G. Transforming growth factor-beta receptor-1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. in press. 2-1-0002.

    Google Scholar 

  • Bevan, S., Woodford-Richens, K., Rozen, P., Eng, C., Young, J., Dunlop, M., Neale, K., Phillips, R., Markie, D., Rodriguez-Bigas, M., Leggett, B., Sheridan, E., Hodgson, S., Iwama, T., Eccles, D., Bodmer, W., Houlston, R., & Tomlinson, I. (1999). Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome. Gut, 45, 406–408.

    CAS  PubMed  Google Scholar 

  • Bizik, J., Felnerova, D., Grofova, M., & Vaheri, A. (1996). Active transforming growth factor-beta in human melanoma cell lines—no evidence for plasmin-related activation of latent tgf-beta. Journal of Cellular Biochemistry, 62, 113–122.

    Article  CAS  PubMed  Google Scholar 

  • Brown, C. B., Boyer, A. S., Runyan, R. B., & Barnett, J. V. (1999). Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science, 283, 2080–2082.

    CAS  PubMed  Google Scholar 

  • Calin, G. A., Gafa, R., Tibiletti, M. G., Herlea, V., Becheanu, G., Cavazzini, L., Barbanti-Brodano, G., Nenci, I., Negrini, M., & Lanza, G. (2000). Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathological parameters: A study of the TGF beta RII, BAX, HMSH3, HMSH6, IGFIIR and BLM genes. International Journal of Cancer, 89, 230–235.

    Article  CAS  Google Scholar 

  • Calonge, M. J. & Massague, J. (1999). Smad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells. Journal of Biological Chemistry, 19:274, 33637–33643.

    Google Scholar 

  • Cardillo, M. R., Petrangeli, E., Perracchio, L., Salvatori, L., Ravenna, L., Di, Silverio, F, (2000). Transforming growth factor-beta expression in prostate neoplasia. Analytical & Quantitative Cytology & Histology, 22, 1–10.

    CAS  Google Scholar 

  • Cheifetz, S., Weatherbee, J. A., Tsang, M. L., Anderson, J. K., Mole, J. E., Lucas, R., & Massague, J. (1987). The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell, 48, 409–415.

    Article  CAS  PubMed  Google Scholar 

  • Chen, C. R., Kang, Y., & Massague, J. (2001). Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proceedings of the National Academy of Sciences of the United States of America, 98, 992–999.

    CAS  PubMed  Google Scholar 

  • Chen, T., de Vries, E. G., Hollema, H., Yegen, H. A., Vellucci, V. F., Strickler, H. D., Hildesheim, A., & Reiss, M. (1999). Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int. J Cancer, 82, 43–51.

    Article  CAS  PubMed  Google Scholar 

  • Chen, T., Triplett, J., Dehner, B., Hurst, B., Colligan, B., Pemberton, J., Graff, J. R., & Carter, J. H. (2001). Transforming growth factor-beta receptor type i gene is frequently mutated in ovarian carcinomas. Cancer Research. 61. 4679–4682.

    CAS  PubMed  Google Scholar 

  • Chen, T. P., Carter, D., Garrigueantar, L., & Reiss, M. (1998). Transforming growth factor beta type i receptor kinase mutant associated with metastatic breast cancer. Cancer Research, 58, 4805–4810.

    CAS  PubMed  Google Scholar 

  • Chen, Y. G., Liu, F., & Massague, J. (1997). Mechanism of tgf-beta receptor inhibition by fkbp12. EMBO Journal, 16, 3866–3876.

    CAS  PubMed  Google Scholar 

  • Chopra, V., Dinh, T. V., & Hannigan, E. V. (1998). Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Investigation, 16, 152–159.

    CAS  PubMed  Google Scholar 

  • Chu, T. Y., Lai, J. S., Shen, C. Y., Liu, H. S., & Chao, C. F. (1999). Frequentaberration of the transforming growth factor-beta receptor II gene in cell lines but no apparent mutation in preinvasive and invasive carcinomas of the uterine cervix. International Journal of Cancer, 80, 506–510.

    Article  CAS  Google Scholar 

  • Comerci, J. T., Runowicz, C. D., Fields, A. L., Romney, S. L., Palan, P. R., Kadish, A. S., & Goldberg, G. L. (1997). Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene. Clinical Cancer Research, 3, 157–160.

    CAS  PubMed  Google Scholar 

  • Conrad, C. T., Ernst, N. R., Dummer, W., Brocker, E. B., & Becker, J. C. (1999). Differential expression of transforming growth factor beta 1 and interleukin 10 in progressing and regressing areas of primary melanoma. Journal of Experimental & Clinical Cancer Research, 18, 225–232.

    CAS  Google Scholar 

  • Crawford, S. E., Stellmach, V., Murphyullrich, J. E., Ribeiro, S. F., Lawler, J., Hynes, R. O., Boivin, G. P., & Bouck, N. (1998). Thrombospondin-1 is a major activator of tgf-beta-1 in vivo. Cell, 93, 1159–1170.

    Article  CAS  PubMed  Google Scholar 

  • Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., & Akhurst, R. J. (1996). Tgf-beta-1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86, 531–542.

    Article  CAS  PubMed  Google Scholar 

  • Dai, J. L., Bansal, R. K., & Kern, S. E. (1999). G(l) cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: Phenotypes reversed by a tumorigenic mutation. Proceedings of the National Academy of Sciences of the United States of America, 96, 1427–1432.

    CAS  PubMed  Google Scholar 

  • Datto, M. B., Li, Y., Panus, J. P., Howe, D. J., Xiong, Y., & Wang, X. F. (1995). Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proceedings of the National Academy of Sciences of the United States of America, 92, 5545–5549.

    CAS  PubMed  Google Scholar 

  • De Geest, K., Bergman, C. A., Turyk, M. E., Frank, B. S., & Wilbanks, G. D. (1994). Differential response of cervical intraepithelial and cervicalcarcinomacell lines to transforming growth factor-beta 1. Gynecologic Oncology, 55,: 376–85.

    CAS  PubMed  Google Scholar 

  • de Jonge, R, R., Garrigue-Antar, L., Vellucci, V. F., & Reiss, M. (1997). Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells. Oncol.Res., 9, 89–98.

    PubMed  Google Scholar 

  • de Visser, K. E. & Kast, W, M. (1999). Effects of TGF-beta on the immune system: implications for cancer immunotherapy [Review]. Leukemia, 13, 1188–1199.

    PubMed  Google Scholar 

  • Dejonge, R. R., Garrigueantar, L., Vellucci, V, F., & Reiss, M. (1997). Frequent inactivation of the transforming growth factor beta type ii receptor in small-cell lung carcinoma cells. Oncology Research, 9, 89–98.

    CAS  Google Scholar 

  • Derynck, R., Akhurst, R. J., & Balmain, A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat.Genet., 29, 117–129.

    Article  CAS  PubMed  Google Scholar 

  • Dey, A., Atcha, I. A., & Bagchi, S. (1997). Hpvl6 e6 oncoprotein stimulates the transforming growth factor-beta-1 promoter in fibroblasts through a specific gc-rich sequence. Virology, 228, 190–199.

    Article  CAS  PubMed  Google Scholar 

  • Duval, A., Gayet, J., Zhou, X. P., Lacopetta, B., Thomas, G., & Hamelin, R. (1999). Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Research, 59, 4213–4215.

    CAS  PubMed  Google Scholar 

  • Ebert, M. P. A., Yu, J., Miehlke, S., Fei, G,, Lendeckel, U., Ridwelski, K., Stolte, M, Bayerdorffer, E., Malfertheiner, P. (2000). Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucose of first-degree relatives of patients with gastric cancer. British Journal of Cancer, 82, 1795–1800.

    Article  CAS  PubMed  Google Scholar 

  • Eisma, R. J., Spiro, J. D., Vonbiberstein, S. E., Lindquist, R., & Kreutzer, D. L. (1996). Decreased expression of transforming growth factor beta receptors on head and neck squamous cell carcinoma tumor cells. American Journal of Surgery, 172, 641–645.

    Article  CAS  PubMed  Google Scholar 

  • Engel, J. D., Kundu, S. D., Yang, T., Yang, S., Goodwin, S., Janulis, L., Cho, J. S., Chang, J., Kim, S. J., & Lee, C. (1999). Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (RENCA) cells. urology, 54, 164–170.

    Article  CAS  PubMed  Google Scholar 

  • Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., & Attisano, L. (1996). Madr2 maps to 18q21 and encodes a tgfbeta-regulated mad-related protein that is functionally mutated in colorectal carcinoma. Cell, 86, 543–552.

    Article  CAS  PubMed  Google Scholar 

  • Evangelou, A., Jindal, S. K., Brown, T. J., Letarte, M. (2000). Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells. Cancer Research, 60, 929–935.

    CAS  PubMed  Google Scholar 

  • Fortunel, N., Hatzfeld, J., Kisselev, S., Monier, M. N., Ducos, K., Cardoso, A., Batard, P., Hatzfeld, A. (2000). Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay. Stem Cells, 18, 102–111.

    Article  CAS  PubMed  Google Scholar 

  • Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C. H., & Miyazono, K. (1993). Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell, 75, 681–692.

    Article  CAS  PubMed  Google Scholar 

  • Friedl, W., Kruse, R., Uhlhaas, S., Stolte, M., Schartmann, B., Keller, K. M., Jungck, M., Stern, M., Loff, S., Back, W., Propping, P., & Jenne, D. E. (1999). Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients. Genes. Chromosomes & Cancer, 25, 403–406.

    CAS  Google Scholar 

  • Geng, Y. & Weinberg, R. A. (1993). Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc. Natl. Acad. Sci. U.S.A, 90, 10315–10319.

    CAS  PubMed  Google Scholar 

  • Go, C., Li, P., & Wang, X. J. (1999). Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: A mechanism associated with increased angiogenesis. Cancer Research, 59, 2861–2868.

    CAS  PubMed  Google Scholar 

  • Goggins, M., Shekher, M., Turnacioglu, K., Yeo, C. J., Hruban, R. H., & Kern, S. E. (1998). Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Research, 58, 5329–5332.

    CAS  PubMed  Google Scholar 

  • Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., Thiagalingam, S., Lutterbaugh, J. D., Neumann, A., Brattain, M. G., Chang, J., Kim, S. J., Kinzler, K. W., Vogelstein, B., Willson, J. V., & Markowitz, S. (1999). Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Research, 59, 320–324.

    CAS  PubMed  Google Scholar 

  • Gryfe, R., Kim, H., Hsieh, E. T. K., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M, Gallinger, S. (2000). Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. New England Journal of Medicine, 342, 69–77.

    Article  CAS  PubMed  Google Scholar 

  • Guo, R. J., Wang, Y., Kaneko, E., Wang, D, Y., Arai, H., Hanai, H., Takenoshita, S., Hagiwara, K., Harris, C. C., & Sugimura, H. (1998). Analyses of mutation and loss of heterozygosity of coding sequences of the entire transforming growth factor beta type ii receptor gene in sporadic human gastric cancer. Carcinogenesis, 19, 1539–1544.

    Article  CAS  PubMed  Google Scholar 

  • Hahn, S. A., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Schutte, M., Rozenblum, E., Seymour, A. B., Weinstein, C. L., Yeo, C. J., Hruban, R. H., & Kern, S. E. (1996). Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Research, 56, 490–494.

    CAS  PubMed  Google Scholar 

  • Haines, J., Dunford, R., Moody, J., Ellender, M., Cox, R., Silver, A. (2000). Loss of heterozygosity in spontaneous and X-ray-induced intestinal tumors arising in FI hybrid Min mice: Evidence for sequential loss of Apc(+) and Dpc4 in tumor development. Genes, Chromosomes & Cancer, 28, 387–394.

    CAS  Google Scholar 

  • Hannon, G, J. & Beach, D. (1994). P15ink4b is a potential effector of tgf-beta-induced cell cycle arrest [see comments]. Nature, 371, 257–261.

    Article  CAS  PubMed  Google Scholar 

  • Hata, A., Lo, R. S., Wotton, D., Lagna, G., & Massague, J. (1997). Mutations increasing autoinhibition inactivate tumour suppressors smad2 and smad4. Nature, 388, 82–87.

    CAS  PubMed  Google Scholar 

  • Hata, A., Shi, Y. G., & Massague, J. (1998). Tgf-beta signaling and cancer — structural and functional consequences of mutations in smads [Review]. Molecular Medicine Today, 4, 257–262.

    CAS  PubMed  Google Scholar 

  • Heldin, C. H., Miyazono, K., & Tendijke, P. (1997). Tgf-beta signalling from cell membrane to nucleus through smad proteins [Review]. Nature, 390, 465–471.

    Article  CAS  PubMed  Google Scholar 

  • Hougaard, S., Norgaard, P., Abrahamsen, N., Moses, H. L., Spang-Thomsen, M., & Poulsen, H. S. (1999). Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines, British Journal of Cancer, 79, 1005–1011.

    Article  CAS  PubMed  Google Scholar 

  • Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F, A., Petersen, G. M., Velculescu, V. E., Traverso, G., & Vogelstein, B. (2001). Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat. Genet., 28, 184–187.

    Article  CAS  PubMed  Google Scholar 

  • Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Jarvinen, H. J., Sistonen, P., Tomlinson, I. M., Houlston, R. S., Bevan, S., Mitros, F. A., Stone, E. M., & Aaltonen, L. A. (1998). Mutations in the smad4/dpc4 gene in juvenile polyposis. Science, 280, 1086–1088

    Article  CAS  PubMed  Google Scholar 

  • Hurd, S, D., Johnson, M, D., Forbes, J. T., Carty-Dugger, T. L., & Arteaga, C. L. (1992). NEUTRALIZING TGF BETA ANTIBODIES INCREASE NATURALKILLER (NK) CELL ACTIVITY AND INHIBIT HUMAN BREAST CANCER CELL TUMORIGENICITY IN ATHYMIC MICE (MEETING ABSTRACT). Proc, Annu, Meet, Am, Assoc, Cancer Res., 33: A481–A481.

    Google Scholar 

  • Iacopetta, B. J., Soong, R., House, A. K., & Hamelin, R. (1999). Gastric carcinomas with microsatellite instability: Clinical features and mutations to the TGF-beta type II receptor, IGFII receptor, and BAX genes. Journal of Pathology, 187, 428–432.

    Article  CAS  PubMed  Google Scholar 

  • Ilyas, M., Efstathiou, J. A., Straub, J., Kim, H. C., & Bodmer, W. F. (1999). Transforming growth factor beta stimulation of colorectal cancer cell lines: Type II receptor bypass and changes in adhesion molecule expression. Proceedings of the National Academy of Sciences of the United States of America, 96, 3087–3091.

    Article  CAS  PubMed  Google Scholar 

  • Im, Y. H., Kim, H. T., Kim, I. Y., Factor, V. M., Hahm, K. B., Anzano, M., Jang, J. J., Flanders, K., Haines, D. C., Thorgeirsson, S. S., Sizeland, A., & Kim, S. J. (2001). Heterozygous Mice for the Transforming Growth Factor-ta Type II Receptor Gene Have Increased Susceptibility to Hepatocellular Carcinogenesis. Cancer Research, 61, 6665–6668.

    Google Scholar 

  • Ishisaki, A., Yamato, K., Nakao, A., Nonaka, K., Ohguchi, M., Tendijke, P., & Nishihara, T. (1998). Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse by cells. Journal of Biological Chemistry, 273, 24293–24296.

    Article  CAS  PubMed  Google Scholar 

  • Kang, S. H., Bang, Y. J., Im, Y. H., Yang, H. K., Lee, D. A., Lee, H. Y., Lee, H. S., Kim, N. K., & Kim, S. J. (1999). Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Oncogene, 18, 7280–7286.

    Article  CAS  PubMed  Google Scholar 

  • Karcher, J., Reisser, C., Daniel, V., & Herold-Mende, C. (1999). Cytokine expression of transforming growth factor-beta 2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels [German]. HNO, 47, 879–884.

    Article  CAS  PubMed  Google Scholar 

  • Kim, J. J., Baek, M. J., Kim, L., Kim, N. G., Lee, Y. C., Song, S. Y., Noh, S. H., & Kim, H. (1999a). Accumulated frameshift mutations at coding nucleotide repeats during the progression of gastric carcinoma with microsatellite instability. Laboratory Investigation, 79, 1113–1120.

    CAS  PubMed  Google Scholar 

  • Kim, S. K., Fan, Y., Papadimitrakopoulou, V., Clayman, G., Hittelman, W. N., Hong, W. K., Lotan, R., & Mao, L. (1996). Dpc4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Research, 56, 2519–2521.

    CAS  PubMed  Google Scholar 

  • Kim, W. S., Park, C., Jung, Y. S., Kim, H. S., Han, J. H., Park, C. H., Kim, K., Kim, J., Shim, Y. M., & Park, K. (1999b). Reduced transforming growth factor-beta type II receptor (TGF-beta RII) expression in adenocarcinoma of the lung. Anticancer Research, 19, 301–306.

    CAS  PubMed  Google Scholar 

  • Kleeff, J., Friess, H., Simon, P., Susmallian, S., Buchler, P., Zimmermann, A., Buchler, M. W., & Korc, M. (1999). Overexpression of Smad2 and colocalization with TGF-beta(l) in human pancreatic cancer. Digestive Diseases & Sciences, 44, 1793–1802.

    CAS  Google Scholar 

  • Knobloch, T, J., Lynch, M. A., Song, H., Degroff, V. L., Casto, B. C., Adams, E. M., Alam, K. Y., Lang, J. C., Schuller, D. E., & Weghorst, C. M, (2001). Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers. Mutat.Res, 479, 131–139.

    CAS  PubMed  Google Scholar 

  • Kong, F. M., Jirtle, R. L., Huang, D. H., Clough, R. W., & Anscher, M. S. (1999). Plasma transforming growth factor-beta 1 level before radiotherapy correlates with long term outcome of patients with lung carcinoma. Cancer, 86, 1712–1719.

    Article  CAS  PubMed  Google Scholar 

  • Korchynskyi, O., Landstrom, M., Stoika, R., Funa, K., Heldin, C. H., ten Dijke, P., & Souchelnytskyi, S. (1999). Expression of Smad proteins in human colorectal cancer. International Journal of Cancer 19:82. 197–202.

    Google Scholar 

  • Krasagakis, K., Tholke, D., Farthmann, B., Eberle, J., Mansmann, U., & Orfanos, C. E. (1998). Elevated plasma levels of transforming growth factor (Tgf)-Beta-l and tgf-beta-2 in patients with disseminated malignant melanoma. British Journal of Cancer, 77, 1492–1494.

    CAS  PubMed  Google Scholar 

  • Kretzschmar, M., Doody, J., Timokhina, I., & Massague, J. (1999). A mechanism of repression of TGF beta/Smad signaling by oncogenic Ras. Genes & Development, 13, 804–816.

    CAS  Google Scholar 

  • Kundu, S. D., Kim, I. Y., Zelner, D., Janulis, L., Goodwin, S., Engel, J. D., & Lee, C. (1998). Absence of expression of transforming growth factor-beta type ii receptor is associated with an aggressive growth pattern in a murine renal carcinoma cell line, renca. Journal of Urology, 160, 1883–1888.

    Article  CAS  PubMed  Google Scholar 

  • Lallemand, F., Mazars, A., Prunier, C., Bertrand, F., Kornprost, M., Gallea, S., Roman-Roman, S., Cherqui, G., & Atfi, A. (2001). Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene, 20, 879–884.

    Article  CAS  PubMed  Google Scholar 

  • Lamm, M. G., Sintich, S. M., & Lee, C. (1998). A proliferative effect of transforming growth factor-beta-1 on a human prostate cancer cell line, tsu-prl. Endocrinology, 139, 787–790.

    Article  CAS  PubMed  Google Scholar 

  • Lange, D., Persson, U., Wollina, U., ten Dijke, P., Castelli, E., Heldin, C. H., & Funa, K. (1999). Expression of TGF-beta related Smad proteins in human epithelial skin tumors. International Journal of Oncology, 14, 049–1056.

    Google Scholar 

  • Latil, A., Pesche, S., Valeri, A., Fournier, G., Cussenot, O., & Lidereau, R. (1999). Expression and mutational analysis of the MADR2/smad2 gene in human prostate cancer. Prostate, 40, 225–231.

    Article  CAS  PubMed  Google Scholar 

  • Lazzereschi, D., Ranieri, A., Mincione, G., Taccogna, S., Nardi, F., & Colletta, G. (1997). Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type ii messenger rna and protein. Cancer Research, 57, 2071–2076.

    CAS  PubMed  Google Scholar 

  • Li, D. Y., Sorensen, L. K., Brooke, B. S., Urness, L. D., Davis, E. C., Taylor, D. G., Boak, B. B., & Wendel, D. P. (1999). Defective angiogenesis in mice lacking endoglin. Science, 284, 1534–1537.

    CAS  PubMed  Google Scholar 

  • Lin, H. Y., Wang, X. F., Ng-Eaton, E., Weinberg, R. A., & Lodish, H. F. (1992). Expression cloning of the tgf-beta type ii receptor, a functional transmembrane serine/threonine kinase [published erratum appears in cell 1992 sep 18;70(6):following 1068]. Cell, 68, 775–785.

    Article  CAS  PubMed  Google Scholar 

  • Liu, F., Pouponnot, C., & Massague, J. (1997). Dual role of the smad4/dpc4 tumor suppressor in tgf-beta-inducible transcriptional complexes. Genes & Development, 11, 3157–3167.

    CAS  Google Scholar 

  • Lopez-Casillas, F., Cheifetz, S., Doody, J., Andres, J. L., Lane, W. S., & Massague, J. (1991). Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-beta receptor system. Cell, 67, 785–795.

    CAS  PubMed  Google Scholar 

  • Lu, S. L., Kawabata, M., Imamura, T., Akiyama, Y., Nomizu, T., Miyazono, K., & Yuasa, Y. (1998). Hnpcc associated with germline mutation in the tgf-beta type ii receptor gene. Nature Genetics, 19, 17–18.

    CAS  PubMed  Google Scholar 

  • Lu, S. L., Kawabata, M., Imamura, T., Miyazono, K., & Yuasa, Y. (1999). Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene. Biochemical & Biophysical Research Communications, 259, 385–390.

    CAS  Google Scholar 

  • Lynch, M. A., Nakashima, R., Song, H, J., Degroff, V. L., Wang, D., Enomoto, T., & Weghorst, C. M. (1998). Mutational analysis of the transforming growth factor beta receptor type ii gene in human ovarian carcinoma. Cancer Research, 58, 4227–4232.

    CAS  PubMed  Google Scholar 

  • Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R S., Zborowska, E., Kinzler, K. W., & Vogelstein, B. (1995). Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability [see comments], Science, 268, 1336–1338.

    CAS  PubMed  Google Scholar 

  • Massague, J. (1998). Tgf-beta signal transduction [Review]. Annual Review of Biochemistry, 67, 753–791.

    Article  CAS  PubMed  Google Scholar 

  • Massague, J. & Chen, Y. G. (2000). Controlling TGF-beta signaling [Review]. Genes & Development, 14, 627–644.

    CAS  Google Scholar 

  • Massague, J., Wotton, D., Receptors, Signal, t., Smad, Tgf, b., & Transcription. (2000). Transcriptional control by the TGF-beta/Smad signaling system [Review]. EMBO Journal, 19, 1745–1754.

    Article  CAS  PubMed  Google Scholar 

  • McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Market, D. S., McKinnon, W. C., Murrell, J., & et al (1994). Endoglin, a tgf-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics, 8, 345–351.

    Article  CAS  PubMed  Google Scholar 

  • Miyaki, M., Iijima, T., Konishi, M., Sakai, K., Ishii, A., Yasuno, M., Hishima, T., Koike, M., Shitara, N., Iwama, T., Utsunomiya, J., Kuroki, T., & Mori, T. (1999). Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene, %20;18, 3098–3103.

    CAS  Google Scholar 

  • Moskaluk, C. A., Hruban, R. H., Schutte, M., Lietman, A. S., Smyrk, T., Fusaro, L., Fusaro, R., Lynch, J., Yeo, C. J., Jackson, C. E., Lynch, H. T., & Kern, S. E. (1997). Genomic sequencing of dpc4 in the analysis of familial pancreatic carcinoma. Diagnostic Molecular Pathology, 6, 85–90

    Article  CAS  PubMed  Google Scholar 

  • Munger, J. S., Huang, X. Z., Kawakatsu, H., Griffiths, M. D., Dalton, S. L., Wu, J. F., Pittet, J. F., Kaminski, N, Garat, C., Matthay, M. A., Rifkin, D. B., & Sheppard, D. (1999). The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell, 96, 319–328.

    Article  CAS  PubMed  Google Scholar 

  • Murata, M., Iwao, K., Miyoshi, Y., Nagasawa, Y., Ohta, T., Shibata, K., Oda, K., Wada, H., Tominaga, S., Matsuda, Y., Ohsawa, M., Nakamura, Y., & Shimano, T. (2000). Molecular and biological analysis of carcinoma of the small intestine: beta-cateningene mutation by interstitial deletion involving exon 3 and replication error phenotype. American Journal of Gastroenterology, 95, 1576–1580

    CAS  PubMed  Google Scholar 

  • Myeroff, L. L., Parsons, R., Kim, S. J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bang, Y. J., Lee, H. Y., Park, J. G., Lynch, H. T., Roberts A. B., Vogelstein, B., & Markowitz, S. D. (1995). A transforming growth factor beta receptor type ii gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Research, 55, 5545–5547.

    CAS  PubMed  Google Scholar 

  • Nakanishi, Y., Kodama, J., Yoshinouchi, M., Tokumo, K., Kamimura, S., Okuda, H., & Kudo, T. (1997). The expression of vascular endothelial growth factor and transforming growth factorbeta associates with angiogenesis in epithelial ovarian cancer. International Journal of Gynecological Pathology, 16, 256–262.

    CAS  PubMed  Google Scholar 

  • Oft, M., Heider, K. H., & Beug, H. (1998). Tgf-beta signaling is necessary for carcinoma cell invasiveness and metastasis. Current Biology, 8, 1243–1252.

    Article  CAS  PubMed  Google Scholar 

  • Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., & Reichmann, E. (1996). Tgf-beta-1 and ha-ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes & Development, 10, 2462–2477.

    CAS  Google Scholar 

  • Ogasa, H., Noma, T., Murata, H., Kawai, S., & Nakazawa, A. (1996). Cloning of a cdna encoding the human transforming growth factor-beta type ii receptor — heterogeneity of the mrna. Gene, 181, 185–190.

    Article  CAS  PubMed  Google Scholar 

  • Ohue, M., Tomita, N., Monden, T., Miyoshi, Y., Ohnishi, T., Izawa, H., Kawabata, Y., Sasaki, M., Sekimoto, M., Nishisho, L, Shiozaki, H., & Monden, M. (1996). Mutations of the transforming growth factor beta type II receptorgene and microsatellite instability in gastric cancer. Int. J Cancer, 68, 203–206.

    Article  CAS  PubMed  Google Scholar 

  • Papadimitrakopoulou, V. A., Oh, Y., Elnaggar, A., Izzo, J., Clayman, G., & Mao, L. (1998). Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer. Clinical Cancer Research, 4, 539–544.

    CAS  PubMed  Google Scholar 

  • Park, B. J., Park, J. I., Byun, D. S., Park, J. H., Chi, S. G., & sgchi@nms.kyunghee.ac.kr (2000). Mitogenic conversion of transforming growth factor-beta 1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. Cancer Research, 60, 3031–3038.

    CAS  PubMed  Google Scholar 

  • Park, K., Kim, S. J., Bang, Y. J., Park, J. G., Kim, N. K., Roberts, A. B., & Sporn, M. B. (1994). Genetic changes in the transforming growth factor beta (tgf-beta) type ii receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by tgf-beta. Proceedings of the National Academy of Sciences of the United States of America, 91, 8772–8776.

    CAS  PubMed  Google Scholar 

  • Parsons, R., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1995). Microsatellite instability and mutations of the transforming growth factor beta type ii receptor gene in colorectal cancer. Cancer Research, 55, 5548–5550.

    CAS  PubMed  Google Scholar 

  • Pasche, B., Bian, Y. S., Reich, J., Rademaker, A., Kolachana, P., & Offit, K. (2001). TraR-I(6A) in colorectal cancer: a new twist? Cancer Research, 61, 8351.

    Google Scholar 

  • Pasche, B., Kolachana, P., Nafa, K., Satagopan, J., Chen, Y. G., Lo, R. S., Brener, D., Yang, D., Kirstein, L., Oddoux, C., Ostrer, H., Vineis, P., Varesco, L., Jhanwar, S., Luzzatto, L., Massague, J., & Offit, K. (1999). T beta R-I(6A) is a candidate tumor susceptibility allele. Cancer Research, 59, 5678–5682

    CAS  PubMed  Google Scholar 

  • Pasche, B., Luo, Y., Rao, P. H., Nimer, S. D., Dmitrovsky, E., Caron, P., Luzzatto, L., Offit, K., Cordoncardo, C., Renault, B., Satagopan, J. M., Murty, V. S., & Massague, J. (1998). Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Research, 58, 2727–2732.

    CAS  PubMed  Google Scholar 

  • Pepper, M. S, (1997). Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev., 8, 21–43.

    Article  CAS  PubMed  Google Scholar 

  • Perry, K. T., Anthony, C. T., Case, T., & Steiner, M, S. (1997). Transforming growth factor beta as a clinical biomarker for prostate cancer. urology, 49, 151–155.

    Article  CAS  PubMed  Google Scholar 

  • Pierce, D. F., Jr., Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., Jr., & Moses, H. L. (1995). Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proceedings of the National Academy of Sciences of the United States of America, 92, 4254–4258.

    CAS  PubMed  Google Scholar 

  • Prunier, C., Mazars, A., Noe, V., Bruyneel, E., Mareel, M., Gespach, C., & Atfi, A. (1999). Evidence that Smad2 is a tumor suppressor implicated in the control of cellular invasion. Journal of Biological Chemistry, 274, 22919–22922.

    Article  CAS  PubMed  Google Scholar 

  • Rashid, A., Zahurak, M., Goodman, S. N., & Hamilton, S, R. (1999), Geneticepidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas. Gut, 44, 826–833.

    CAS  PubMed  Google Scholar 

  • Reed, J. A., McNutt, N. S., Prieto, V. G., & Albino, A. P. (1994). Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion, implications for tumor progression. American Journal of Pathology, 145, 97–104.

    CAS  PubMed  Google Scholar 

  • Renault, B., Calistri, D., Buonsanti, G., Nanni, O., Amadori, D., & Ranzani, G. N. (1996). Microsatellite instability and mutations of p53 and tgf-beta rii genes in gastric cancer. Human Genetics, 98, 601–607.

    Article  CAS  PubMed  Google Scholar 

  • Roth, S., Sistonen, P., Salovaara, R., Hemminki, A., Loukola, A., Johansson, M., Avizienyte, E., Cleary, K. A., Lynch, P., Amos, C. I., Kristo, P., Mecklin, J. P., Kellokumpu, I., Jarvinen, H., & Aaltonen, L. A. (1999). SMAD genes in juvenile polyposis. Genes. Chromosomes & Cancer, 26, 54–61.

    CAS  Google Scholar 

  • Saito, H., Tsujitani, S., Oka, S., Kondo, A., Ikeguchi, M., Maeta, M., & Kaibara, N. (1999). The expression of transforming growth factor-beta 1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer, 86, 1455–1462.

    Article  CAS  PubMed  Google Scholar 

  • Samowitz, W. S. & Slattery, M. L. (1997). Transforming growth factor-betareceptor type 2 mutations and microsatellite instability in sporadic colorectal adenomas and carcinomas. American Journal of Pathology, 151, 33–35.

    CAS  PubMed  Google Scholar 

  • Santin, A. D., Hermonat, P. L., Hiserodt, J. C., Fruehauf, J., Schranz, V., Barclay, D., Pecorelli, S., & Parham, G. P. (1997). Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecologic Oncology, 64, 477–480.

    Article  CAS  PubMed  Google Scholar 

  • Schiemann, W. P., Pfeifer, W. M., Levi, E., Kadin, M. E., & Lodish, H. F. (1999). A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood, 94, 2854–2861

    CAS  PubMed  Google Scholar 

  • Schmid, P., Itin, P., & Rufli, T. (1995). In situ analysis of transforming growth factor-beta-s (tgf-beta-1, tgf-beta-2, tgf-beta-3), and tgf-beta type ii receptor expression in malignantmelanoma. Carcinoaenesis, 16, 1499–1503.

    CAS  Google Scholar 

  • Schultz-Cherry, S., Chen, H., Mosher, D. F., Misenheimer, T. M., Krutzsch, H. C., Roberts, D. D., & Murphy-Ullrich, J. E. (1995). Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. Journal of Biological Chemistry, 270, 7304–7310.

    CAS  PubMed  Google Scholar 

  • Schutte, M. (1999). DPC4/SMAD4 gene alterations in human cancer, and their functionalimplications. Annals of Oncology, 10, 4–59.

    Article  Google Scholar 

  • Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Jr., Meltzer, P. S., Hahn, S. A., & Kern, S. E, (1996). Dpc4 gene in various tumor types. Cancer Research, 56, 2527–2530.

    CAS  PubMed  Google Scholar 

  • Schwarte-Waldhoff, I., Klein, S., Blass-Kampmann, S., Hintelmann, A., Eilert, C., Dreschers, S., Kalthoff, H., Hahn, S. A., & Schmiegel, W. (1999). DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene, 20: 18, 3152–3158.

    Google Scholar 

  • Shin, K. H., Park, Y. J., Park, J. G. (2000). Mutationalanalysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Clinical Cancer Research, 6, 536–540.

    CAS  PubMed  Google Scholar 

  • Sinha, S., Nevett, C., Shuttleworth, C. A., & Kielty, C. M. (1998). Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins [Review]. MatrixBiology, 17, 529–545.

    CAS  Google Scholar 

  • Takaku, K., Oshima, M., Miyoshi, H., Matsui, M., Seldin, M. F., & Taketo, M. M. (1998). Intestinal tumorigenesis in compound mutant mice of both dpc4 (Smad4) And apc genes. Cell, 92, 645–656

    Article  CAS  PubMed  Google Scholar 

  • Tanaka, S., Mori, M., Mafune, K., Ohno, S., Sugimachi, K. (2000). A dominant negative mutation of transforming growth factor-betareceptor type II gene in microsatellite stable oesophageal carcinoma. British Journal of Cancer, 82, 1557–1560.

    Article  CAS  PubMed  Google Scholar 

  • Tang, B., Bottinger, E, P., Jakowlew, S. B., Bagnall, K. M., Mariano, J., Anver, M. R., Letterio, J. J., & Wakefield, L. M. (1998). Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat.Med., 4, 802–807.

    Article  CAS  PubMed  Google Scholar 

  • Tarafa, G., Villanueva, A., Farre, L., Rodriguez, J., Musulen, E., Reyes, G., Seminago, R., Olmedo, E., Paules, A. B., Peinado, M. A., Bachs, O., Capella, G. (2000). DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination. Oneogene, 19, 546–555.

    CAS  Google Scholar 

  • Teti, A., Degiorgi, A., Spinella, M, T., Migliaccio, S., Canipari, R., Muda, A. O., & Faraggiana, T. (1997). Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro. International Journal of Cancer, 72, 1013–1020.

    Article  CAS  Google Scholar 

  • Togo, G., Okamoto, M., Shiratori, Y., Yamaji, H., Kato, J., Matsumura, M., Sano, T., Motojima, T., & Omata, M. (1999). Does mutation of transforming growth factor-beta type II receptor gene play an important role in colorectal polyps? Digestive Diseases & Sciences, 44, 1803–1809.

    CAS  Google Scholar 

  • Tokunaga, H., Lee, D. H., Kim, I. Y., Wheeler, T. M., & Lerner, S. P. (1999). Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients. Clinical Cancer Research, 5, 2520–2525.

    CAS  PubMed  Google Scholar 

  • Tomita, S., Miyazato, H., Tamai, O., Muto, Y., & Toda, T. (1999). Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic human gastrointestinal cancer. Cancer Genetics & Cytogenetics, 115, 23–27.

    CAS  Google Scholar 

  • Villanueva, A., Garcia, C., Paules, A. B., Vicente, M., Megias, M., Reyes, G., Devillalonga, P., Agel, N., Lluis, F., Bachs, O., & Capella, G. (1998). Disruption of the antiproliferative tgf-beta signaling pathways in human pancreatic cancer cells. Oncogene, 17, 1969–1978.

    Article  CAS  PubMed  Google Scholar 

  • Wagner, M., Kleeff, J., Lopez, M. E., Bockman, I., Massaque, J., & Korc, M. (1998). Transfection of the type i tgf-beta receptor restores tgf-beta responsiveness in pancreatic cancer. International Journal of Cancer, 78, 255–260.

    Article  CAS  Google Scholar 

  • Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K., &. (1995a). Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells, J Biol.Chem., 270, 22044–22049.

    CAS  PubMed  Google Scholar 

  • Wang, J., Sun, L. Z., Myeroff, L., Wang, X. F., Gentry, L. E., Yan, J. H., Liang, J. R,, Zborowska, E., Markowitz, S., Willson, J. K. V., & Brattain, M. G. (1995b). Demonstration that mutation of the type ii transforming growthfactor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. Journal of Biological Chemistry, 270, 22044–22049.

    CAS  PubMed  Google Scholar 

  • Watanabe, T., Wu, T. T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A, B., III, & Hamilton, S. R. (2001). Molecular predictors of survivalafter adjuvant chemotherapy for colon cancer. N.Engl.J Med., 344, 1196–1206.

    Article  CAS  PubMed  Google Scholar 

  • Wikstrom, P., Bergh, A., Damber, J. E., Tgf, b., Regulation of, p. g., Metastasis, Angiogenesis., & Immunosuppression. (2000). Transforming growth factor-beta 1 and prostate cancer [Review]. Scandinavian Journal of Urology & Nephrology, 34, 85–94.

    CAS  Google Scholar 

  • Wolff, J. M., Fandel, T. H., Borchers, H., & Jakse, G. (1999). Serum concentrations of transforming growth factor-beta 1 in patients with benign and malignant prostatic diseases. Anticancer Research, 19, 2657–2659.

    CAS  PubMed  Google Scholar 

  • Woodford-Richens, K., Williamson, J., Bevan, S., Young, J., Leggett, B., Frayling, I., Thway, Y., Hodgson, S., Kim, J. C., Iwama, T., Novelli, M., Sheer, D., Poulsom, R., Wright, N., Houlston, R., & Tomlinson, I. (2000). Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium. Cancer Research, 60, 2477–2482.

    CAS  PubMed  Google Scholar 

  • Wu, S. P., Theodorescu, D., Kerbel, R. S., Willson, J. K., Mulder, K. M., Humphrey, L. E., & Brattain, M. G. (1992). Tgf-beta 1 is an autocrine-negative growth regulator of human colon carcinoma fet cells in vivo as revealed by transfection of an antisense expression vector. Journal of Ceil Biology, 116, 187–196.

    CAS  Google Scholar 

  • Xu, J. & Attisano, L. (2000). Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Proceedings of the National Academy of Sciences of the United States of America, 97, 4820–4825.

    CAS  PubMed  Google Scholar 

  • Xu, J. W., Ahmad, A., Jones, J. F., Dolcetti, R., Vaccher, E., Prasad, U., & Menezes, J. (2000). Elevated serum transforming growth factor beta 1 levels in Epstein-Barr virus-associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM. Journal of Virology, 74, 2443–2446.

    Article  CAS  PubMed  Google Scholar 

  • Yakicier, M. C., Irmak, M. B., Romano, A., Kew, M., & Ozturk, M. (1999). Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene, 18, 4879–4883.

    Article  CAS  PubMed  Google Scholar 

  • Yamada, S. D., Baldwin, R. L., & Karlan, B. Y. (1999). Ovarian carcinoma cell cultures are resistant to TGF-beta 1-mediated growth inhibition despite expression of functional receptors. Gynecologic Oncology, 75, 72–77.

    Article  CAS  PubMed  Google Scholar 

  • Yamada, Y., Miyauchi, A., Goto, J., Takagi, Y., Okuizumi, H., Kanematsu, M., Hase, M., Takai, H., Harada, A., & Ikeda, K. (1998), Association of a polymorphism of the transforming growth factor-beta-1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. Journal of Bone & Mineral Research, 13, 1569–1576.

    CAS  Google Scholar 

  • Yamada, Y., Okuizumi, H., Miyauchi, A., Takagi, Y., Ikeda, K., & Harada, A. (2000). Association of transforming growth factor beta 1 genotype with spinal osteophytosis in Japanese women. Arthritis & Rheumatism, 43, 452–460.

    Article  CAS  Google Scholar 

  • Yanagisawa, K., Osada, H., Masuda, A., Kondo, M., Saito, T., Yatabe, Y., Takagi, K., & Takahashi, T. (1998). Induction of apoptosis by smad3 and down-regulation of smad3 expression in response to tgf-beta in human normal lung epithelial cells. Oncogene, 17, 1743–1747.

    Article  CAS  PubMed  Google Scholar 

  • Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massague, J., Mundy, G. R., & Guise, T. A. (1999). TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. Journal of Clinical Investigation, 103, 197–206.

    CAS  PubMed  Google Scholar 

  • Yokota, M., Ichihara, S., Lin, T. L., Nakashima, N., Yamada, Y. (2000). Association of a t29→C polymorphism of the transforming growth factor-beta 1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation, 101, 2783–2787.

    CAS  PubMed  Google Scholar 

  • Zhang, T., Nanney, L. B., Peeler, M. O., Williams, C. S., Lamps, L., Heppner, K. J., Dubois, R, N., & Beauchamp, R. D. (1997). Decreased transforming growth factor beta type ii receptor expression in intestinal adenomas from min/+ mice is associated with increased cyclin dl and cyclin-dependent kinase 4 expression. Cancer Research, 57, 1638–1643

    CAS  PubMed  Google Scholar 

  • Zhou, Y., Kato, H., Shan, D., Minami, R., Kitazawa, S., Matsuda, T., Arima, T., Barrett, J. C., & Wake, N. (1999). Involvement of mutations in the DPC4 promoter in endometrial carcinoma development. Molecular Carcinogenesis, 25, 64–72.

    Article  CAS  PubMed  Google Scholar 

  • Ziv, E., Cauley, J., Morin, P. A., Saiz, R., & Browner, W. S. (2001). Association between the T29→C polymorphism in the transforming growth factorbetal gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. JAMA, 285, 2859–2863.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology Department of Medicine, Northwestern University Medical School, Chicago, IL

    Yansong Bian, Virginia Kaklamani, Jennifer Reich & Boris Pasche

  2. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL

    Yansong Bian, Virginia Kaklamani, Jennifer Reich & Boris Pasche

Authors
  1. Yansong Bian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virginia Kaklamani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer Reich
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Boris Pasche
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA

    David A. Frank MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Kluwer Academic Publishers

About this chapter

Cite this chapter

Bian, Y., Kaklamani, V., Reich, J., Pasche, B. (2004). TGF-β Signaling Alterations in Cancer. In: Frank, D.A. (eds) Signal Transduction in Cancer. Cancer Treatment and Research, vol 115. Springer, Boston, MA. https://doi.org/10.1007/0-306-48158-8_3

Download citation

  • DOI: https://doi.org/10.1007/0-306-48158-8_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7340-3

  • Online ISBN: 978-0-306-48158-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation